Citations 3

A Phase 3 Trial of Brepocitinib in Dermatomyositis

New England Journal of Medicine | March 28, 2026 | Volume: 394 | Issue: 19 | Pages: 1883-1893

10.1056/nejmoa2503531 | PMID 41910335

Shaping the landscape of interstitial lung disease in idiopathic inflammatory myopathies: state of the art, evidence gaps and a need for clinical trials

Clinical and Experimental Rheumatology | February 24, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.55563/clinexprheumatol/rsnsu2 | PMID 41738254

Shared governance of international myositis networks

Clinical and Experimental Rheumatology | February 24, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.55563/clinexprheumatol/dfli8l | PMID 41738253